160 related articles for article (PubMed ID: 21682567)
1. Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas.
Zhuang Z; Qi M; Li J; Okamoto H; Xu DS; Iyer RR; Lu J; Yang C; Weil RJ; Vortmeyer A; Lonser RR
J Neurosurg; 2011 Oct; 115(4):789-95. PubMed ID: 21682567
[TBL] [Abstract][Full Text] [Related]
2. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289
[TBL] [Abstract][Full Text] [Related]
3. p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma.
Barresi V; Mondello S; Branca G; Rajan TS; Vitarelli E; Tuccari G
Hum Pathol; 2015 Feb; 46(2):231-8. PubMed ID: 25476123
[TBL] [Abstract][Full Text] [Related]
4. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas.
Neder L; Marie SK; Carlotti CG; Gabbai AA; Rosemberg S; Malheiros SM; Siqueira RP; Oba-Shinjo SM; Uno M; Aguiar PH; Miura F; Chammas R; Colli BO; Silva WA; Zago MA
Brain Pathol; 2004 Oct; 14(4):399-405. PubMed ID: 15605987
[TBL] [Abstract][Full Text] [Related]
6. Molecular markers that identify human astrocytomas and oligodendrogliomas.
Popko B; Pearl DK; Walker DM; Comas TC; Baerwald KD; Burger PC; Scheithauer BW; Yates AJ
J Neuropathol Exp Neurol; 2002 Apr; 61(4):329-38. PubMed ID: 11939588
[TBL] [Abstract][Full Text] [Related]
7. Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging.
Rijpkema M; Schuuring J; van der Meulen Y; van der Graaf M; Bernsen H; Boerman R; van der Kogel A; Heerschap A
NMR Biomed; 2003 Feb; 16(1):12-8. PubMed ID: 12577293
[TBL] [Abstract][Full Text] [Related]
8. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of ABCA2' a possible molecular marker for oligodendrogliomas.
Soichi O; Masanori N; Hideo T; Kazunori A; Nobuya I; Jun-ichi K
Neurosurgery; 2007 Apr; 60(4):707-14; discussion 714. PubMed ID: 17415208
[TBL] [Abstract][Full Text] [Related]
10. Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas.
Decaestecker C; Lopes BS; Gordower L; Camby I; Cras P; Martin JJ; Kiss R; VandenBerg SR; Salmon I
J Neuropathol Exp Neurol; 1997 Apr; 56(4):391-402. PubMed ID: 9100670
[TBL] [Abstract][Full Text] [Related]
11. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
[TBL] [Abstract][Full Text] [Related]
12. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
Capper D; Reuss D; Schittenhelm J; Hartmann C; Bremer J; Sahm F; Harter PN; Jeibmann A; von Deimling A
Acta Neuropathol; 2011 Feb; 121(2):241-52. PubMed ID: 21069360
[TBL] [Abstract][Full Text] [Related]
13. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
Gupta M; Djalilvand A; Brat DJ
Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
[TBL] [Abstract][Full Text] [Related]
14. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
Reuss DE; Sahm F; Schrimpf D; Wiestler B; Capper D; Koelsche C; Schweizer L; Korshunov A; Jones DT; Hovestadt V; Mittelbronn M; Schittenhelm J; Herold-Mende C; Unterberg A; Platten M; Weller M; Wick W; Pfister SM; von Deimling A
Acta Neuropathol; 2015 Jan; 129(1):133-46. PubMed ID: 25427834
[TBL] [Abstract][Full Text] [Related]
15. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
[TBL] [Abstract][Full Text] [Related]
16. ADAM 12: a putative marker of oligodendrogliomas?
Kanakis D; Lendeckel U; Theodosiou P; Dobrowolny H; Mawrin C; Keilhoff G; Bukowska A; Dietzmann K; Bogerts B; Bernstein HG
Dis Markers; 2013; 34(2):81-91. PubMed ID: 23324579
[TBL] [Abstract][Full Text] [Related]
17. Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.
Luider TM; Kros JM; Sillevis Smitt PA; van den Bent MJ; Vecht CJ
Electrophoresis; 1999; 20(4-5):1087-91. PubMed ID: 10344289
[TBL] [Abstract][Full Text] [Related]
18. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors.
Hirose T; Ishizawa K; Shimada S
Neuropathology; 2010 Dec; 30(6):586-96. PubMed ID: 20408960
[TBL] [Abstract][Full Text] [Related]
19. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
[TBL] [Abstract][Full Text] [Related]
20. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]